• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

COA Praises HHS for Proposing to End Rebate System

Article

The Community Oncology Alliance (COA) applauded President Donald Trump, HHS Secretary Alex Azar, Inspector General Daniel Levinson, and HHS staff for staking a strong stance against rebates and proposing to overal the current system.

The Community Oncology Alliance (COA) applauded President Donald Trump, HHS Secretary Alex Azar, Inspector General Daniel Levinson, and HHS staff for staking a strong stance against rebates and proposing to overal the current system. ASaccording to COA, the proposal will lower drug prices for all Americans by ensuring that they receive negotiated drug discounts, rather then plan sponsors and pharmacy benefit managers (PBMs).

COA also encouraged the administration to fix direct and indirect renumeration fees that PBMs get from pharmacy providers, which also drive up drug list prices. Read the full press release.

Related Videos
David Awad, PharmD, BCOP
H. John Beardsley, MBA, and Fauzea Hussain, MPH, sitting for a video interview
Dr Margrit Wiesendanger
Ibrahim Aldoss, MD, associate professor, City of Hope
Manmeet Ahluwalia, MD, MBA, FASCO, chief of medical oncology, chief scientific officer, and deputy director of the Miami Cancer Institute of Baptist Health South Florida
Cathy Eng, MD, FACP, FASCO
Dr Margrit Wiesendanger
Nini Wu, MD, Navista
Fred Locke, MD, Moffitt Cancer Center and Research Institute
Dr Margrit Wiesendanger
Related Content
© 2025 MJH Life Sciences
AJMC®
All rights reserved.